Skip to main content
Joshua Halpern, MD, Urology, New York, NY

JoshuaAHalpernMDMS

Urology New York, NY

Male Infertility, Male Sexual Dysfunction

Chief Scientific Officer and Regional Medical Director

Dr. Halpern is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Halpern's full profile

Already have an account?

Summary

  • Dr. Joshua Halpern MD MS is a board-certified and fellowship-trained Reproductive Urologist practicing in New York and throughout the Northeast. He serves as both the Regional Medical Director in the Northeast and Chief Scientific Officer for Posterity Health. He is also on faculty at Northwestern University Feinberg School of Medicine.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2013 - 2018
  • Weill Cornell Graduate School of Medical Sciences
    Weill Cornell Graduate School of Medical SciencesMS, Health Policy and Economics, 2015 - 2016
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Internship, Surgery, 2012 - 2013
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2012, MD, Alpha Omega Alpha

Certifications & Licensure

  • RI State Medical License
    RI State Medical License 2024 - 2026
  • IL State Medical License
    IL State Medical License 2018 - 2026
  • CO State Medical License
    CO State Medical License 2024 - 2025
  • DE State Medical License
    DE State Medical License 2023 - 2025
  • NY State Medical License
    NY State Medical License 2016 - 2025
  • NJ State Medical License
    NJ State Medical License 2023 - 2025
  • NH State Medical License
    NH State Medical License 2023 - 2025
  • American Board of Urology Urology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Health News | Online Platforms Give Access to Testosterone Therapy Without Caution: Study
    Health News | Online Platforms Give Access to Testosterone Therapy Without Caution: StudyDecember 5th, 2022
  • Direct-to-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone Therapy
    Direct-to-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone TherapyDecember 5th, 2022
  • Direct-to-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone Therapy
    Direct-to-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone TherapyDecember 4th, 2022
  • Join now to see all